← Feed

$PALI

2 theses
bullish 100%neutral 0%bearish 0%
Avg return (3m)
—
Win rate (3m)
— (0 resolved)
1d3d1w1m3m6m1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$PALIr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish
u/Avish_Golakiya · 73d ago23 prior · awaiting results
“long several of these”

5 of the 6 biotech names I posted 5 weeks ago hit their catalyst (and the 1 that hasn't)

FDA cleared IND for PALI-2108 and authorized a global Phase 2 in ulcerative colitis (June 29), showing asymmetric risk-reward despite early stage and future capital needs.

original post →
$PALIr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish
u/Avish_Golakiya · 90d ago23 prior · awaiting results
“no explicit position stated; author calls it the one with real asymmetry and recommends sizing accordingly”

Upcoming penny stock catalysts for June/July 2026 in Biotech and Pharma

PALI's Phase 1b data in fibrostenotic Crohn's came in positive in March, with thick sell-side coverage (Piper Sandler, Wolfe, Stifel, HC Wainwright at Buy) and $18.50 consensus price target against current $2 stock. The main risks are pre-Phase 2 efficacy execution and upcoming capital raise.

original post →

End of results.